Clinical Trial Update: A Randomized, Placebo-Controlled Trial to Examine the Efficacy of Oral Donepezil in Subjects With MCI [NA]

View source ↗

Summary

Pfizer-sponsored randomized, placebo-controlled trial evaluated donepezil for mild cognitive impairment, with Alzheimer's disease listed as a condition; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• Donepezil (donepezil)

Snippet

Sponsor: Pfizer | Conditions: Alzheimer's Disease | NA | Status: COMPLETED